Brain Health Alliance Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2021
NCT04390009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Brain Health Alliance

Active Ingredients

Drugs in Phase 1 Trials (1)

florbetapir (Amyvid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 1)

Sclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1